The COVID-19 Prevention and Treatment Handbook published by The First Affiliated Hospital, Zheijang University School of Medicine is a guide containing clinical experience in treating the new COVID-19.
In the second part: Diagnosis and Treatment, in Chapter IX. The Balance of Intestinal Microecology and Nutritional Support, we can read:
“ Some COVID-19 patients have gastrointestinal symptoms (such as abdominal pain and diarrhea) due to direct viral infection of the intestinal mucosa or antiviral and anti-infective drugs. There has been report that the intestinal microecological balance is broken in COVID-19 patients, manifesting a significant reduction of the intestinal probiotics such as lactobacillus and bifidobacterium. Intestinal microecological imbalance may lead to bacterial translocation and secondary infection, so it is important to maintain the balance of intestinal microecology by microecological modulator and nutritional support.
Microecologics Intervention
(1) Microecologics can reduce bacterial translocation and secondary infection. It can increase dominant gut bacteria, inhibit intestinal harmful bacteria, reduce toxin production and reduce infection caused by gut microflora dysbiosis.
(2) Microecologics can improve the gastrointestinal symptoms of patients. It can reduce water in feces, improve fecal character and defecation frequency, and reduce diarrhea by inhibiting intestinal mucosal atrophy”.
More information can be found at: https://esge.org/documents/Handbook_of_COVID-19_Prevention_and_Treatment.pdf
2 comments on “What PROBIOTICS have to do with COVID-19?”
Comments are closed.